Q1 2021 Agile Therapeutics Inc Earnings Call Transcript
Good afternoon, and welcome to the Agile Therapeutics First Quarter 2021 Financial Results Conference Call. Please note today's event is being recorded.
I would now like to turn the conference over to Matt Riley, Head of Investor Relations.
Hello, everyone, and welcome to today's conference call to discuss our first quarter 2021 financial results and corporate update. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future, management's expectations for our future financial and operational performance, our business strategy, our assessment of the combined hormonal contraceptive market, and the potential market share for Twirla among other statements regarding our plans, prospects and expectations.
Such statements represent our judgment as of today, are not promises or guarantees and may involve risks and uncertainties that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |